Uroprotection in patients receiving cyclophosphamide and ifosfamide.
Munshi
N C
NC
Loehrer
P J
PJ
Williams
S D
SD
D000171:Acrolein / Q000633:toxicity*; D003520:Cyclophosphamide / Q000009:adverse effects*; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects*; D013438:Sulfhydryl Compounds / Q000494:pharmacology*; D014551:Urinary Tract / Q000187:drug effects*; D014570:Urologic Diseases / Q000517:prevention & control*
D013438:Sulfhydryl Compounds; D000171:Acrolein; D003520:Cyclophosphamide; D007069:Ifosfamide